MET Genetic Abnormalities Unreliable for Patient Selection for Therapeutic Intervention in Oropharyngeal Squamous Cell Carcinoma

BACKGROUND: Identification of MET genetic alteration, mutation, or amplification in oropharyngeal squamous cell carcinoma (OPSCC) could lead to development of MET selective kinase inhibitors. The aim of this study was to assess the frequency and prognostic value of MET gene mutation, amplification,...

Descripción completa

Detalles Bibliográficos
Autores principales: Lacroix, Ludovic, Post, Sophie F., Valent, Alexander, Melkane, Antoine E., Vielh, Philippe, Egile, Coumaran, Castell, Christelle, Larois, Christelle, Micallef, Sandrine, Saulnier, Patrick, Goulaouic, Hélène, Lefebvre, Anne-Marie, Temam, Stéphane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3894941/
https://www.ncbi.nlm.nih.gov/pubmed/24465403
http://dx.doi.org/10.1371/journal.pone.0084319

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3894941/
https://www.ncbi.nlm.nih.gov/pubmed/24465403
http://dx.doi.org/10.1371/journal.pone.0084319

Ejemplares similares